Soligenix Inc Soligenix (NASDAQ: SNGX) is Soaring today. Here’s Why Soligenix, Inc. (NASDAQ: SNGX) has disclosed that the Office of Orphan Products Development of the U.S. FDA has awarded orphan drug designation to the active ingredient hypericin for the cure of T-cell lymphoma.